/

Empresas

Hi

No verificado

HistoSonics

Sobre qué escribimos

Medicina - VariosMultimediaOncologíaSaludSanidad

18 Comunicados de prensa

Ver todos los comunicados de prensa

22/06/2026

HistoSonics Announces Financing with Participation from Yosemite Among Other Strategic Investors

Fuente

Editor

1.00

0

18/05/2026

HistoSonics Receives Landmark TFDA Approval in Taiwan, Accelerating Global Expansion

Fuente

Editor

1.00

0

11/05/2026

HistoSonics Moves to Advance Additional Histotripsy Applications Announcing FDA Submission for Kidney Tumors

Fuente

Editor

1.00

0

30/03/2026

HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)

Fuente

Editor

1.00

0

22/10/2025

HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members

Fuente

Editor

1.00

0

07/08/2025

Multimedia

Tercera edad

Sanidad

Medicina nuclear

Ciencia

Oncología

Software

Material médico sanitario

Hardware

Ir de compras

Técnica

Medicina - Varios

Higiene alimentaria

Biotecnología

Salud

Mercado de valores

HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors

Fuente

Editor

1.00

0

14/07/2025

HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 7 Million Blue Cross Blue Shield Highmark Members

Fuente

Editor

1.00

0

10/06/2025

Multimedia

Salud

Ir de compras

Medicina nuclear

Medicina - Varios

Asociaciones/Profesionales

Oncología

Ciencia

Material médico sanitario

Sanidad

Tercera edad

Industria

HistoSonics and Cambridge University Unveil Europe’s First Edison™ Histotripsy System Powered by Li Ka Shing Foundation Gift

Fuente

Editor

1.00

0

06/06/2025

HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors

Fuente

Editor

1.00

0

29/05/2025

HistoSonics’ Edison Histotripsy System Gains Great Britain Early Market Access Under Unmet Clinical Needs Authorisation

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0